Dr. Kim Rice Addresses Outcomes in Kidney Transplantation in The New England Journal of Medicine

Dr. Kim M. Rice recently co-authored, Belatacept and Long-Term Outcomes in Kidney Transplantation, in The New England Journal of Medicine which concluded that seven years after transplantation, patient and graft survival and the mean eGFR were significantly higher with belatacept than with cyclosporine.

Dr. Rice joined Dallas Nephrology Associates in 1998 and is board certified in nephrology and internal medicine.  Dr. Rice practices at our Dallas Landry and Dallas Viceroy offices as well as Dallas Transplant Institute.